IHC remains the principal diagnostic technique, with 3+ scores or 2+ scores accompanied by ERBB2-positive fluorescence in situ hybridization (FISH) results defining HER2-positive BC [372,373]. This evidence concerns the gene ERBB2 and breast cancer.